kneat.com, inc. Share Price

Equities

KSI

CA4988241010

Software

Market Closed - Toronto S.E. 20:34:07 26/04/2024 BST 5-day change 1st Jan Change
3.78 CAD 0.00% Intraday chart for kneat.com, inc. +0.27% +23.93%

Financials

Sales 2024 * 47.06M 34.4M 2.76B Sales 2025 * 63.19M 46.19M 3.7B Capitalization 323M 236M 18.9B
Net income 2024 * -15M -10.96M -878M Net income 2025 * -15M -10.96M -878M EV / Sales 2024 * 6.99 x
Net Debt 2024 * 5.94M 4.34M 348M Net Debt 2025 * 9.91M 7.25M 580M EV / Sales 2025 * 5.27 x
P/E ratio 2024 *
-22.7 x
P/E ratio 2025 *
-26.1 x
Employees 293
Yield 2024 *
-
Yield 2025 *
-
Free-Float 75.34%
More Fundamentals * Assessed data
Dynamic Chart
1 week+0.27%
Current month+0.80%
1 month-1.82%
3 months+5.59%
6 months+33.10%
Current year+23.93%
More quotes
1 week
3.72
Extreme 3.72
3.80
1 month
3.45
Extreme 3.45
3.80
Current year
2.90
Extreme 2.9
3.90
1 year
2.45
Extreme 2.45
3.90
3 years
2.16
Extreme 2.16
4.85
5 years
1.05
Extreme 1.05
4.85
10 years
0.31
Extreme 0.31
4.85
More quotes
Managers TitleAgeSince
Founder - 11/12/13
Founder - 11/12/13
Founder - 11/12/13
Members of the board TitleAgeSince
Director/Board Member 53 13/01/14
Director/Board Member 58 30/01/22
Chairman - 26/06/16
More insiders
Date Price Change Volume
26/04/24 3.78 0.00% 44,381
25/04/24 3.78 +0.80% 9,653
24/04/24 3.75 0.00% 40,699
23/04/24 3.75 -0.53% 5,696
22/04/24 3.77 0.00% 7,675

Delayed Quote Toronto S.E., April 26, 2024 at 08:34 pm

More quotes
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.78 CAD
Average target price
4.358 CAD
Spread / Average Target
+15.30%
Consensus